Spondylitis
Ankylosing Spondylitis
search
Ankylosing Spondylitis
, Juvenile Ankylosing Spondylitis
Epidemiology
Strong Association with
HLA-B27
HLA-B27
positive in up to 95% of AS cases
Only 2% of
HLA-B27
develop Ankylosing Spondylitis
Populations with higher
Incidence
HLA-B27
positive
Native Americans
Asian populations (except Japanese)
European and United States Caucasian
Men more often affected by ration of 3:1
Onset between
Puberty
and age 40 years
Low
Prevalence
Groups
South American Indians
Japanese
African-Americans
Diagnosis
Criteria
Back pain
Starts with dull low back radiating to gluteal area
Progresses up spine to ultimately involve neck
Onset before age 40 years (may occur as early as 13)
Insidious onset
Duration longer than 3 months
Pain worse in the morning
Morning stiffness lasts longer than 30 minutes
Pain decreases with
Exercise
or activity
Pain provoked by prolonged inactivity or lying down
Pain accompanied with constitutional Symptoms
Anorexia
Malaise
Low grade fever
Articular Symptoms and Signs
Monoarticular Arthritis
or
Oligoarticular Arthritis
Asymmetric and nonerosive
Arthritis
Common joint involvement
Inflammatory low back (esp.
Sacroiliitis
)
Large joints:
Shoulder
s
Hips (Hip Flexion contractures with rigid gait)
Peripheral joint involvement more common in women
Women have less axial skeleton involvement
Costosternal
Pleuritic Chest Pain
Heel Pain
Achilles tendon insertion at
Calcaneus
Plantar fascia insertion at
Calcaneus
Systemic Signs
Acute
Anterior Uveitis
(Nongranulomatous)
Occurs in 20-40% of Ankylosing Spondylitis
Microscopic Colitis
(often asymptomatic)
Occurs in 25-40% of Ankylosing Spondylitis
Cardiac involvement rare
Aortic Insufficiency
Aortitis
Conduction defects
Arrhythmia
s
Pulmonary Involvement
Restrictive Lung Disease
Restricted costovertebral mobility
Apical lobe fibrosis
Neurologic Involvement
Spine
Fracture
s or dislocations
Cauda Equina Syndrome
Atlantoaxial subluxation
Complications of Late Spondyloarthropathy
Spondylodiscitis
Cauda Equina Syndrome
Pseudoarthrosis with
Spinal Cord Compression
Resultant neurologic deficits
Exam
Observation of back
Lumbar lordosis flattened
Thoracic kyphosis exaggerated
Cervical Spine
hyperextended
Tests for Sacroiliac Joint Inflammation
Gaenslen's Test
Patrick's Test
Tests for range of motion loss at
Lumbar Spine
Schober's Test
Decreased lateral bending and lumbar extension
Radiology
Anteroposterior
Pelvis XRay
Usually sufficient as only XRay confirmation
Reveals bilateral and symmetric
Sacroiliitis
Sclerosis may be present (usually not in children)
Later findings include erosions or SI joint fusion
Spine XRay other findings
Initial
Bony sclerosis appears as squaring of
Vertebra
e
Next
Osteitis of
Vertebra
l margins
Late
Annulus fibrosus ossifies
Syndesmophytes between
Vertebra
e
Classic "Bamboo" spine (<10%) appearance
Progresses up spine
Special XRay views
Ferguson's View (specialized sacroiliac view)
Other studies with limited indications
Bone Scan
CT or MRI spine
Labs
HLA-B27
Assay
Not recommended for routine testing
Nonspecific: Present in up to 10% of Caucasians
Acute phase reactants
Gene
ral
Increased in up to 70% of Ankylosing Spondylitis
Not correlated with disease activity or severity
Markers
C-Reactive Protein
(CRP)
Erythrocyte Sedimentation Rate
(ESR)
Management
Non-pharmacologic
Regular therapeutic
Exercise
Erect
Posture
Firm mattress (without a pillow)
Deep breathing
Exercise
s
Maintain normal chest expansion
Spinal extension
Exercise
s
Range of Motion
Exercise
s
Cervical Spine
Shoulder
s
Hips
Knee
s
Consider physical therapy
Management
Medications
First Line:
NSAID
S
Indomethacin
(up to maximum of 50 mg PO tid)
Tolmetin
400 mg PO tid-qid
Second Line:
NSAID
refractory cases or
NSAID
Adjuncts
Sulfasalazine
2-4g/day divided doses
Effective peripheral
Arthritis
Less effective for axial skeleton symptoms
Methotrexate
Effective for peripheral but not axial
Arthritis
Local
Corticosteroid
s injection
For persistent synovitis and enthesopathy
Other agents potential benefit
Pamidronate
(
Aredia
) IV
Tumor Necrosis Factor
alpha agents
Etanercept
(
Enbrel
)
Infliximab
(
Remicade
)
Braun (2003) Ann Rheum Dis 62:817-24 [PubMed]
Medications to avoid
Avoid long term
Systemic Corticosteroid
s
Not generally effective in Ankylosing Spondylitis
Avoid gold and
Penicillamine
References
Inman in Klippel (1997) Primer Rheumatic, p. 189-93
van der Linden in Ruddy (2001) Kelley's Rheum, p. 1039
Dougados (2002) Ann Rheum Dis 61 [PubMed]
Kataria (2004) Am Fam Physician 69:2853-60 [PubMed]
Type your search phrase here